Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Other Non-Current Liabilities (2018 - 2025)

Dna X's Other Non-Current Liabilities history spans 8 years, with the latest figure at $171000.0 for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $171000.0 for Q4 2025, down 89.94% from a year ago — trailing twelve months through Dec 2025 was $171000.0 (down 89.94% YoY), and the annual figure for FY2025 was $171000.0, down 89.94%.
  • Other Non-Current Liabilities for Q4 2025 was $171000.0 at Dna X, down from $1.8 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.8 million in Q3 2025 to a low of $171000.0 in Q4 2025.
  • The 5-year median for Other Non-Current Liabilities is $1.5 million (2023), against an average of $1.4 million.
  • Peak annual rise in Other Non-Current Liabilities hit 16.12% in 2025, while the deepest fall reached 89.94% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $1.4 million in 2021, then grew by 1.42% to $1.4 million in 2022, then increased by 6.93% to $1.5 million in 2023, then grew by 11.19% to $1.7 million in 2024, then tumbled by 89.94% to $171000.0 in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $171000.0, $1.8 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.